Skip to main content

Posts

Showing posts from July, 2019

RIP Primary Prevention Status of Daily Aspirin Intake | Dr. Mubashar A Choudry

At March 17, 2019: The American Heart Association (AHA) and the American College of Cardiology (ACC) released a new guideline for the primary prevention of cardiovascular disease . Mubashar A Choudry MD Mubashar A. Choudry M.D. , F.A.C.C., Chief Medical Officer, Washington Cardiovascular Institute designates this guideline as a “one-stop-shop” for accurate information in the primary prevention of cardiovascular disease.   Mubashar Choudry According to Dr. Choudry, there are four main takeaways from this guideline, which draws largely on the trials mentioned in the previous blog post-  Nix Daily Low-Dose Aspirin – ARRIVE, ASCEND, and ASPREE – the main being that Aspirin isn’t a good preventative medication for reducing risk of cardiovascular disease in most cases. Mubashar A Choudry The new guideline downgraded aspirin as an effective primary prevention method for cardiovascular disease, even giving it a Class III recommendation in two cases, meaning